huntington’s disease - lake forest college

2
What is Huntington’s? Neurodegenerative disease Characterized by aggregates of misfolded proteins If gene is inherited the disease is acquired Can be detected through blood test NO KNOWN CURE Dillon Gilbow, Lauren Leeber, Ashley Reich Biology Department, Lake Forest College, Illinois, 60045 What research is being done for Huntington’s Disease? Why are cells dying specifically in the striatum? Are neural transplants a viable form of treatment? What molecular pathways are there to degrade protein aggregates? Can gene mutations help with possible therapies for HD? Huntingtin Protein A Molecular Look into the Hunt Hunting for Relief mHtt CAG nucleotide sequence AKA: Polyglutamine tract Location: Chromosome 4 Codes for: Glutamine Mutant Huntingtin Function: Not clearly known Normal Htt: <36 repeats CAG Mutant Htt: >36 repeats CAG *More repeats of CAG, the more severe pathology mHtt forms aggregates CAGCAGCAGCAGCAGCAGCAGCAGCAG mHtt mHtt mHtt Huntington’s Disease Treatment for Chorea Symptoms Treatment for Psychiatric Symptoms Tetrabenazine Symptoms Onset v. Repeats Neuroleptics Benzodiazepines Blocks Dopamine Receptors Potentiates GABA Receptors Inhibits VMAT-2 Post Synaptic Membrane Post Synaptic Membrane mHtt Correlation between the number of CAG repeats and age of onset Coronal brain section. Severe striatal atrophy in Huntington’s patient (left) and control (right) The Hunt for Knowledge Pathway in Huntington’s Disease Huntinton’s Neuron v. Normal Neuron George Huntington http://upload.wikimedia.org/wikipedia/commons/9/9f/Georgehuntington.jpg Post Synaptic Membrane Post Synaptic Membrane Reuptake Selective Serotonin Reuptake Inhibitors Presynaptic Membrane Serotonin Serotonin References Acknowledgments Phases of signs and symptoms as disease progresses Cattaneo, E., Rigamonti, D., Zuccato, C. (2002) Enigma of Huntington’s Disease. Scientific American. 92-97. Andrich, J., Epplen, J.T., (2006) Hunting for Answers. Scientific American. 70-75. Hayden, M.R., Kremer, B. Huntington’s Disease in The Metabolic and Molecular Bases of Inherited Disease, (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.)843896 (McGraw-Hill, Inc., New York, 1995). "Huntington's Disease Information Page." National Institute of Neurological Disorders and Stroke (NINDS). Web. 02 Apr. 2010. <http://www.ninds.nih.gov/disorders/huntington/huntington.htm>. Lauren, Allie and Dillon would like to thank their peer mentors Keith Solvang, Liza Pahomov, and Abbey Pipkorn for taking so much time out of their busy schedule to offer their guidance and wisdom. We would also like to thank Alina Konnikova, as well as the other Bio346 students. A special thanks to Dr. DebBurman for his never-ending willingness to help us this semester. CAG Repeats Death Age

Upload: others

Post on 03-Feb-2022

1 views

Category:

Documents


0 download

TRANSCRIPT

What is Huntington’s? • Neurodegenerative disease

• Characterized by aggregates of misfolded proteins

• If gene is inherited the disease is acquired

• Can be detected through blood test

• NO KNOWN CURE

Dillon Gilbow, Lauren Leeber, Ashley Reich Biology Department, Lake Forest College, Illinois, 60045

What research is being done for Huntington’s Disease?

• Why are cells dying specifically in the striatum?

• Are neural transplants a viable form of treatment?

• What molecular pathways are there to degrade protein aggregates?

• Can gene mutations help with possible therapies for HD?

Huntingtin Protein

A Molecular Look into the Hunt Hunting for Relief

mHtt

CAG nucleotide sequence

AKA: Polyglutamine tract Location: Chromosome 4 Codes for: Glutamine

Mutant Huntingtin

Function: Not clearly known Normal Htt: <36 repeats CAG Mutant Htt: >36 repeats CAG

* More repeats of CAG, the more severe pathology

mHtt forms aggregates

CAGCAGCAGCAGCAGCAGCAGCAGCAG

mHtt

mHtt

mHtt

Huntington’s Disease

Treatment for Chorea Symptoms

Treatment for Psychiatric Symptoms

Tetrabenazine

Symptoms Onset v. Repeats

Neuroleptics Benzodiazepines Blocks Dopamine Receptors Potentiates GABA Receptors Inhibits VMAT-2

Post Synaptic Membrane Post Synaptic Membrane

mHtt

Correlation between the number of CAG repeats and age of onset

Coronal brain section. Severe striatal atrophy in Huntington’s patient (left) and control (right)

The Hunt for Knowledge

Pathway in Huntington’s Disease

Huntinton’s Neuron v. Normal Neuron

George Huntington http://upload.wikimedia.org/wikipedia/commons/9/9f/Georgehuntington.jpg

Post Synaptic Membrane Post Synaptic Membrane

Reuptake

Selective Serotonin Reuptake Inhibitors

Presynaptic Membrane

Serotonin

Serotonin

References

Acknowledgments

Phases of signs and symptoms as disease progresses

• Cattaneo, E., Rigamonti, D., Zuccato, C. (2002) Enigma of Huntington’s Disease. Scientific American. 92-97. • Andrich, J., Epplen, J.T., (2006) Hunting for Answers. Scientific American. 70-75. • Hayden, M.R., Kremer, B. Huntington’s Disease in The Metabolic and Molecular Bases of Inherited Disease, (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.)843−896 (McGraw-Hill, Inc., New York, 1995). • "Huntington's Disease Information Page." National Institute of Neurological Disorders and Stroke (NINDS). Web. 02 Apr. 2010. <http://www.ninds.nih.gov/disorders/huntington/huntington.htm>.

Lauren, Allie and Dillon would like to thank their peer mentors Keith Solvang, Liza Pahomov, and Abbey Pipkorn for taking so much time out of their busy schedule to offer their guidance and wisdom. We would also like to thank Alina Konnikova, as well as the other Bio346 students.

A special thanks to Dr. DebBurman for his never-ending willingness to help us this semester.

CAG Repeats Death

Age

Medical Mysteries of HD Dillon Gilbow, Lauren Leeber, Ashley Reich Biology Department, Lake Forest College, Illinois, 60045

Hunting for Mutants

Rhes binds to mutant huntingtin

Rhes decreases aggregation of mHtt

Rhes acts as an E3 protein in sumoylation

Cysteine is required for mHtt

Reference: Gu, X., et al. (2009) Serines 13 and 16 are Critical Determinants of Full Length Mutant Huntingtin Induced Pathogenesis in HD Mice. Neuron. 64:828-840.

Htt WEAK

Rhes

STRONG

CELL DEATH CELL SURVIVAL

Area of striatal cell death

UBC

E1

Rhes  

E2 E3

Rhes  

Reference: Srinivasa Subramaniam, et al. (2009). Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity. Science. 324:1327-1330.

http://upload.wikimedia.org/wikipedia/commons/thumb/3/33/BrainCaudatePutamen.svg/172px-BrainCaudatePutamen.svg.png

Can dying neurons be replaced as a treatment?

To replace dying cells as a viable treatment

Patient with Huntington’s

Patient still has Huntington’s

More severe case

10 YEARS LATER

Faster Death

Natural Killer

Natural Killer

T cells

T helper

Cell

Rhes

Htt

Inflammatory response

Projection Neuron Death

Hunting for a Treatment

Lysine K444 Lysine K444

HAT

Ac

Why does Htt only kill striatal cells?

Rhes

Rhes   Rhes  

Rhes  

 Rhes  mHtt

mHtt

mHtt

mHtt

1

2

3

4

Hunting for Striatal Cells

GAP

GOAL

FINDINGS

Why is there cell death in the striatum?

Identify the striatal specific protein, Rhes, role in HD

Hunting for a Target

GAP

GOAL

FINDINGS

How can mutant huntingtin protein be degraded?

To target a pathway to degrade mutant huntingtin and increase cell survival.

The lysine of mutant jjjhuntingtin is acetylated by HAT and deacetylated by HDAC.

Inhibition of HDAC and an increase in HAT leads to the degradation of mHtt and increased cell survival.

Mutations on lysine may prevent acetylation and leads to an increase in cell death.

1

2

3

4

GAP

GOAL

FINDINGS

Grafts do not survive long term

Grafted neurons die faster than patient’s neurons

Death of projection neurons

Inflammatory response targets grafts

1

2

3

4

http://blogs.abc.net.au/photos/uncategorized/2008/06/27/body.gif http://scienceblogs.com/purepedantry/upload/2007/04/hippocampus-2.gif

Lysine K444 Lysine K444 HAT

Ac

Lysine K444

Ac

HDAC HDAC

Lysine K444 Ac

Lysine K444

Ac

HDAC HDA

Lysine K444

Ac

Lysine K444 Lysine K444 HAT

Ac

Lysine K444

Arginine R444

Arginine R444

Ac

Arginine R444

2

1

3

4

Reference: Cicchetti, F., et al. (2009). Neural Transplants in Patients with Huntington’s Disease Undergo Disease-like Neuronal Degeneration. PNAS. 106: 12483-12488.

1

2

3 3

References: Jeong, H., et al. (2009). Acetylation Targets Mutant Huntingtin to Autophagosome Degradation. Cell. 137: 60-72.

SA

SD

+/SD

-/SA

-/SD

-/SD

SA/SD

SA/SA

1

2

-/SD -/SD

-/SD -/SA

+/SD

HEALTHY

DEAD

HEALTHY DEAD DEAD

GAP

GOAL

FINDINGS

Can adding mutations on serines 13 and 16 in transgenic mice lead to a possible therapy for Huntington’s Disease?

1

2

A phosphomimetic (SD) mutation or a phosphoresistant (SA) mutation will help relieve motor and behavioral deficits, aggregation, and neurodegeneration.

Mice with the SD mutation live and are healthy, mice with the SA mutation die.

Mice with any of the SA mutation usually died in vitro, all died from HD eventually, those mice with the SD mutation were healthy.

C263 to Serine

1

2.

SA/SA

3